The GHA confirms that Dr Daniel Cassaglia will return to his contracted, substantive post of Medical Director with effect from 7th March 2022. This follows the outcome of a full investigation, a number of legal proceedings, the independent disciplinary board by the GHA and the fact that there are no further pending legal actions on the matter.
It will be recalled that in January a new post of GHA Director General was introduced. This new post carries the responsibilities of Chief Executive and is supported by a team of executive directors, one of which is the Medical Director. Dr Cassaglia will, therefore, be part of this supporting team whilst continuing to work as a consultant paediatrician as he also did previously.
The GHA’s Director General, Patrick Geoghegan OBE, said: ‘I would like to welcome Dr Cassaglia back to his substantive role and sincerely thank Dr Krishna Rawal for his work as Acting Medical Director through the unprecedented and extraordinary time of the COVID-19 Pandemic. Dr Rawal’s role will revert to his substantive post as Deputy Medical Director and he will continue his clinical work as a General Practitioner. I am sure we will all be able to work together for the benefit of the people of Gibraltar, in particular the patients of the GHA. Looking forward to the future I plan to work in close partnership with the GHA senior management team and our staff as we implement our plans to ‘Reset, Restart and Recover.’